Digest Network Come funziona
Network
/
Società
bi
Non verificato

bioAffinity Technologies, Inc.

Di cosa scriviamo

BiotecnologiaMedicina - VarieOncologiaSaluteScienza

80 comunicati stampa

Guarda tutti i comunicati
02/06/2026
Scienza
Biotecnologia
Medicina - Varie
Oncologia
Salute
Tecnica
Web e Social Network
Industria
Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
27/05/2026
Scienza
Medicina nucleare
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
12/05/2026
Industria
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Sanità
Salute
Oncologia
bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
08/05/2026
Mercato azionario
Scienza
Tecnica
Medicina - Varie
Software
Biotecnologia
Salute
Oncologia
bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
28/04/2026
Industria
Tecnica
Scienza
Medicina - Varie
Software
Biotecnologia
Salute
Oncologia
bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
14/04/2026
Industria
Tecnica
Scienza
Medicina - Varie
Software
Biotecnologia
Salute
Oncologia
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
07/04/2026
Eventi
Fiere
Industria
Software
Biotecnologia
Oncologia
Salute
Attrezzature medico-sanitarie
Tecnica
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
01/04/2026
Pubblico Esercizio/Vendita al dettaglio
Industria
Software
Biotecnologia
Oncologia
Salute
Attrezzature medico-sanitarie
Tecnica
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
25/03/2026
Web e Social Network
Industria
Scienza
Medicina nucleare
Biotecnologia
Oncologia
Salute
Medicina - Varie
Sanità
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
17/03/2026
Industria
Scienza
Tecnica
Medicina - Varie
Software
Biotecnologia
Farmaceutica
Salute
Oncologia
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0